Medivis, a New York-based healthcare technology company, announced that its new augmented reality (AR) surgical platform has received FDA approval.

The platform, SurgicalAR, uses AR, AI and computer vision to help surgeons gain new perspective into each procedure.

“Holographic visualization is the final frontier of surgical imaging and navigation,” Osamah Choudhry, MD, an experienced neurosurgeon and the CEO of Medivis, said in a prepared statement. "The surgical world continues to primarily rely on two-dimensional imaging technology to understand and operate on incredibly complex patient pathology."